Why the study?
Do implantable cardiac defibrillators improve outcomes compared to optimal medical therapy in patients with non-ischaemic cardiomyopathy?
Do implantable cardiac defibrillators improve outcomes compared to optimal medical therapy in patients with non-ischaemic cardiomyopathy?
This is a protocol for a Cochrane Review evaluating the efficacy and safety of implantable cardiac defibrillators in patients with non-ischaemic cardiomyopathy.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effects of implantable cardiac defibrillators on patients with non‐ischaemic cardiomyopathy compared to optimal medical therapy, and the adverse events associated with using these devices.
No takes yet. Share an insight, caveat, or question.
Moheb et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: